Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22692677
DOI
10.1002/mds.25066
Knihovny.cz E-resources
- MeSH
- Analysis of Variance MeSH
- Atherosclerosis pathology MeSH
- Biomarkers MeSH
- Blood Vessels pathology MeSH
- Carotid Intima-Media Thickness MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Brain pathology MeSH
- Follow-Up Studies MeSH
- Neuropsychological Tests MeSH
- Parkinson Disease mortality pathology psychology MeSH
- Survival MeSH
- Regression Analysis MeSH
- Aged MeSH
- Cluster Analysis MeSH
- Age Factors MeSH
- Wechsler Scales MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Biomarkers MeSH
BACKGROUND: The effect of brain-vessel pathology on mortality in 57 consecutive PD patients was studied. METHODS: Baseline clinical, neuropsychological, ultrasonographic (US), and MR data obtained from patients who died (n = 18) during a 4-year follow-up period were compared with the data of patients who survived. RESULTS: US/MRI data displayed a more-severe vascular impairment in deceased patients. Differences were significant between both groups with respect to age, clinical and cognitive status, intima-media thickness, and resistance index (indicators of large and small vessel impairment). The sum score of white-matter hyperintensities was significantly higher among decedents. A cluster analysis displayed two clusters that differed in the two parameters (i.e. in age and in sum score). CONCLUSIONS: This study provides evidence that comorbid atherosclerosis and otherwise subclinical impairment of brain vessels may contribute to mortality in PD. The vascular pathology may act in association with other comorbidities on the terrain of progressive neurodegenerative pathology.
References provided by Crossref.org
White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy